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1. Introduction 
Since the discovery of coxsackievirus type B3 (CVB3) more than 50 years ago there has been 
considerable progress in the understanding of viral heart disease. Coxsackievirus was first 
discovered as a filterable agent associated with a paralytic syndrome, so named for its 
identification in Coxsackie, New York (coxsackievirus type A) (Dalldorf and Sickles, 1948). 
Coxsackievirus type B (CVB) was isolated the following year from patients with aseptic 
meningitis and by the mid-1950s an association with acute myocarditis in humans was 
apparent (Melnick et al., 1949). Many other viruses have since been shown to cause 
myocarditis and its long term sequelae, arrhythmias, dilated cardiomyopathy (DCM) and 
heart failure. By example, adenovirus, herpes viruses, and influenza can cause myocarditis 
in humans and models of heart failure. The viral agent most often reported as being the 
cause of viral myocarditis is CVB3. For example, CVB3 RNA can be detected in the heart 
muscle of 10 - 35 % of DCM patients (Feldman and McNamara, 2000; Hosenpud et al., 2001), 
depending on the study cohort. 
1.1 Myocarditis etiologies 
Inflammation of the heart muscle can have many causes, not least of which is viral infection. 
Cocaine [(Jentzen, 1989) reviewed in (Maraj et al., 2010)], virus induced, autoimmune 
(possibly due to resolved microbial infection), and even vaccine induced myocarditis 
(Cassimatis et al., 2004) have all been reported with a wide degree of occurrence. Though 
very rare, the vaccine induced aetiology is classified as idiopathic due to the poorly 
understood mechanism of inflammation. This manifestation of myocarditis is so rare it is 
probably very complex in cause and mechanism, requiring both environmental and genetic 
susceptibility factors of the host to trigger myocardial immune invasion. The subject of this 
chapter is one of the most common forms of myocarditis, and perhaps the most studied: 
myocarditis due to viral infection. In such cases, myocyte dropout and provisional matrix 
fibrosis, focal lesions of immune cell invasion are marked and key observations in the 
diagnosis of these cases.  
1.2 Clinical presentation 
With an experimental understanding of CVB3 induced myocarditis comes a better 
understanding of the breadth of symptoms presented by the admitted patient, before, 
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during and after a hospital visit. The patient is most often admitted to hospital with general 
chest pain or discomfort, combined with other symptoms of an infection, which are often 
suspected as other ailments (Brady et al., 2004). These symptoms of infection can be so 
apparent that they divert the attention of the clinician away from cardiac dysfunction. 
Further work-up of the case reveals elevated creatinine phosphokinase and troponin with 
rhythmic disturbances and reduced cardiac output, often presented by shortness of breath 
with minimal exertion (Brady et al., 2004). Most cases resolve with little or no supportive 
therapy, but a minor percentage of cases progress to dilated cardiomyopathy and congestive 
heart failure, for which there is no cure other than heart transplantation.  
1.3 Diagnosis: the Dallas criteria 
The Dallas criteria for myocarditis are a set of histology based criteria proposed by a 
publication in 1987 by Aretz et al. (Aretz et al., 1987). These criteria rely upon histological 
observations made of left ventricular biopsies, obtained by either the Cordis or Scholten 
bioptomes. Several biopsies of the ventricle are required for a definitive diagnosis and there 
is a high possibility of false negatives using this method. Though not necessarily a problem 
inherent in the method itself but the need for a large number of samples due to the often 
localised and focal nature of the disease. The chances of false negatives combined with 
procedural discomfort are driving forward a need to develop new and less invasive 
procedures like blood-based biomarker-detection. 
The Dallas criteria for diagnosis of myocarditis require an inflammatory infiltrate with 
associated myocyte necrosis, or otherwise damage that is not characteristic of ischemia. Less 
intense immune infiltration with little or no evidence of myocyte destruction is classified as 
borderline myocarditis (Aretz et al., 1987).  
Understanding the etiology of myocarditis will improve the success rate of diagnosis, which 
in turn, improves management of the disease and prognosis (Baughman, 2006; Felker et al., 
2000). The Dallas criteria were a good stepping stone toward a standardised diagnostic 
method, however there remain significant drawbacks to this biopsy based histological 
criteria. It has been demonstrated that myocarditis could only be accurately diagnosed in 25 
% of single biopsies obtained from patients who had died of myocarditis (Chow et al., 1989; 
Hauck et al., 1989), and more than 5 biopsies are required to diagnose myocarditis in two 
thirds of patients (Hauck et al., 1989), and 17 biopsies are required for an 80 % level of 
confidence in diagnosis (Hauck et al., 1989; Schultz et al., 2009). Therefore only positive 
samples obtained by endomyocardial biopsy should be considered diagnostic. These poor 
rates of definitive diagnosis are a product of the small size of the bioptome sample from a 
relatively large area afflicted with a disease that is often focal and of relatively narrow 
localisation. 
The Dallas criteria were a good start for a disease that had no diagnostic criteria at the time 
of publication (1987). To this day, the Dallas criteria are used to diagnose myocarditis from 
endomyocardial biopsies, though the existence of sensitive methods for disease detection, 
particularly in the blood, biomarker discovery should make this methodology 
supplementary or even obsolete. Therefore, there is a need for the development of sensitive 
methods for the differential and definitive diagnosis of non-ischemic cardiomyopathies like 
myocarditis. This chapter will not cover diagnosis or new detection strategies any further as 
these topics are covered in greater detail, elsewhere in this book. 
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2. Viral replication as the central regulator of viral myocarditis 
The advent of virus replication in the heart of an individual is thought to occur secondarily 
to a more general and systemic virus infection (Carthy et al., 1997; Mena et al., 2000; 
Vuorinen et al., 1994), the spleen, gut, pancreas and lymph nodes are often infected; patients 
often report malaise, fatigue and more general ‘flu-like’ symptoms about 1- 2 weeks prior to 
chest pains and cardiac rhythm disturbances. Immune infiltration in the heart has taken 
hold by the time the patient has been seen by a physician and any evidence of direct virus-
induced damage has been superseded by T cell invasion at the foci of infection. It is not 
surprising that there have been many reports that claim the predominant source of damage 
is immune infiltration of the myocardium, as inflammation is what defines this disease. 
Autoimmune etiologies due to an antiviral response gone awry have been proposed as one 
of the major causes of pathology (Lv et al., 2011). Regardless, there are numerous 
publications that suggest a large amount of damage is inflicted by the virus itself, in the 
murine model, early post-infection, that is correlated with the number of myocarditic lesions 
spatially coincident with positivity by in situ hybridization for CVB3 genome (Cheung et al., 
2008; Chow et al., 1992; Marchant et al., 2009a; McManus et al., 1993). These observations are 
supported by findings in autopsy cases, particularly in infants (Iwasaki et al., 1985a; Iwasaki 
et al., 1985b).  
2.1 The cytotoxic nature of enterovirus replication 
Coxsackievirus B3 is a member of the Enteroviridae of the Picornaviridae family, which are 
fast replicating and exquisitely cytotoxic viruses. Another member of this family is 
poliovirus, which is also highly cytotoxic, producing a paralytic syndrome reminiscent of 
the aseptic meningitis and encephalitis sometimes caused by CVB3. The very nature of 
enterovirus replication makes these viruses very cytotoxic because the infected cell must 
burst to permit the release of progeny virus virions for infection of bystander cells and 
further replication cycles. This aspect of CVB3 replication means that every virus infected 
cell will die within 8 – 24 hrs of infection, releasing numerous rounds of progeny virus into 
the heart before the innate immune system has had a chance to control infection. The degree 
of immune infiltration and damage inflicted on the heart muscle is therefore a function of 
the amount of virus inoculum that takes hold in the heart, dictating the degree of damage 
done to the myocardium. 
The virus polarises the protein expression machinery entirely to the benefit of the virus by a 
number of mechanisms and so in combination with the inability of the cell to perform its 
natural housekeeping functions inevitably leads to cell destruction. The viral proteases act to 
cleave capped cellular mRNAs thereby skewing protein translation in the cell from cap-
dependent translation initiation to internal ribosome entry site (IRES) translation. 
Coxsackievirus B3 translates it’s RNA genome via IRES translation initiation so destruction 
of the cell’s own capped mRNAs removes any competition of the virus’ own IRES RNAs for 
the cell’s ribosomes. This usurping of control of the cell’s protein expression machinery 
effectively brings the normal housekeeping function of the cell to a halt.  
The massive amount of protein produced by the virus, devolution of the endoplasmic 
reticulum (ER) and other membranous structures combined with the oxidative stress placed 
upon the cell by virus replication, all destabilise the homeostasis of the infected cell. The 
large protein-nucleic acid aggregates that make up progeny virion are not normal to the cell 
and induce numerous UPR responses; due to their toxic nature, protein aggregates are 
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normally sequestered to vimentin-cytoskeleton encased aggrosomes (Garcia-Mata et al., 
1999; Johnston et al., 1998). For example, the irregular folding of viral proteins can lead to 
sequestering of virus protein products into cellular aggresomes (Spiropoulou et al., 2003). 
These combined facets of CVB3 replication contribute to the inherently toxic nature of virus 
replication, even in the absence of the onset of programmed cell death.  
2.2 Virus entry into the host cell 
The replication cycle of CVB3 in the cell begins in a very similar manner to poliovirus 
infection via receptor mediated endocytosis into the target host cell. Coxsackievirus B3 
binds its cellular receptor(s), the coxsackie-adenovirus receptor (CAR) and ,sometimes, 
decay acceleration factor (DAF), to achieve entry via endocytosis into the host cell. Once the 
virus has achieved delivery inside the cell there is massive rearrangement of internal 
membrane structures and then complete usurping of the host cell protein translation 
machinery for the purposes of virus replication and virion assembly. The RNA polarity 
(positive-polarity RNA) of the CVB3 genome means that viral polypeptide can be translated 
directly after delivery into the host cell. All of the proteins encoded by the CVB3 genome are 
expressed as 1 poly-protein that is then cleaved by virus proteases, 2A and 3C, into the 
individual viral proteins VP4, VP2, VP3, VP1, 2A, 2B, 2C, 3A, 3B, 3C, and 3D.  
2.3 Death and lysis of virus infected cells 
Direct virus-induced damage inflicted by CVB3 upon the infected cell is through 
simultaneous activation of multiple cell death pathways, by direct and indirect mechanisms. 
For example, all of the known caspase cell death activation pathways are activated during 
CVB3 infection: the FAS/FADD receptor-mediated caspase- 8 pathway and the 
mitochondrial cytochrome c -caspase- 9 pathway are activated to ultimately trigger the 
death effector, caspase-3 (Carthy et al., 1998; Carthy et al., 2003). Normally, the activation of 
caspases during apoptosis leads to programmed cell death: cleavage of cellular DNA by 
endonucleases and shrinking of the cell’s contents into a cytoskeleton-vimentin cage, for 
engulfment by phagocytes at some later time. This process is programmed, and most 
importantly, ‘neat,’ preventing the dissemination of the dead cell’s contents throughout the 
tissue. The debris released from cells are hydrolytic and oxidative, some are apoptotic, 
which would lead to bystander necrosis of surrounding cells and tissue if not disposed of 
‘neatly’ through programmed cell death. However, CVB3 infected cells do not die in a 
programmed and neat manner. The act of virus replication; viral proteases and activation of 
numerous cell death pathways all at once cause infected cells to rapidly lyse and release 
cellular contents, along with virus progeny virions, for further rounds of replication in 
surrounding bystander cells.  
Necrotic cell death during CVB3 infection is most likely caused by a myriad of pathways 
that act in concert to result in the uncontrolled lysis of the cell for the purpose of virus 
progeny release. Evolution of the virus has favoured a more chaotic lysis/necrosis type 
death as opposed to a programmed and controlled method of killing the host cell. We will 
summarise the pathways of CVB3 induced cell death below:  
2.3.1 Caspase-induced cell death during CVB3 infection 
The caspase pathways of apoptosis were the first mechanisms of programmed cell death 
that were discovered [(Lazebnik et al., 1994; Miura et al., 1993; Yuan et al., 1993; Yuan and 
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Horvitz, 1990) reviewed in (Yuan and Horvitz, 2004)]. The first cellular pathways implicated 
in cell death due to CVB3 infection were also caspase mediated (Carthy et al., 1998; Colston 
et al., 1998), since these were the predominant mechanisms of cell death being studied at the 
time (Andrade et al., 1998; Atkinson et al., 1998; Barry et al., 2000). As new mechanisms of 
cell death were discovered, such as GSK-3ǃ, some were attributed to virus induced cell 
death. 
Comprehensive studies of caspase cleavage and activation during infection have 
demonstrated a pan-caspase activation profile during viral infection (Carthy et al., 1998; 
Carthy et al., 2003), from activation of the tumour necrosis factor (TNF) receptor activated 
caspase-8 to the mitochondrial cytochrome c release that results in the activation of caspase-
9. All of the above mentioned pathways converge upon the activation of the effector 
caspase, caspase-3. The most notable caspase-8 activated pathway is triggered by Fas ligand 
binding and activation of Fas receptor, a member of the TNF superfamily of receptors. 
Various oxidative states, toxins and aberrant protein expression can lead to a permeable 
mitochondrial membrane that releases cytochrome c into the cytoplasm which leads to 
caspase-9 activation. Though the caspase-8 and -9 pathways are quite different in that they 
are extrinsic and intrinsic pathways of cell death, respectively, they both lead to cleavage 
and activation of caspase-3, a death effector caspase. In cells destined to die by either of 
these routes of apoptosis there is cleavage of poly ADP-ribose polymerase (PARP) and DNA 
fragmentation factor (DFF) by caspase-3. Cleavage of DFF by this caspase reveals an 
endonuclease that enters the nucleus and cleaves DNA, resulting in DNA fragmentation 
(Figure 1A).  
Two of the experimental hallmarks of apoptotic cell death are PARP fragmentation, as 
observed on a Western blot, and fragmented genomic DNA as viewed by agarose gel 
electrophoresis. It was demonstrated that inhibition of caspase-3 PARP and DFF cleavage 
did not inhibit virus induced cell death completely (Carthy et al., 1998), however some 
alleviation of cytopathic effect was notable. The broad spectrum zVAD.fmk caspase 
inhibitor is not 100 % effective at inhibiting all caspases, and there is the possibility that in 
the absence of caspase activation that a redundant mechanism of cell death becomes 
dominant in mediating cytotoxicity. In this scenario we would expect zVAD.fmk to appear 
ineffectual at inhibiting cell death. It was apparent that the caspases were activated though 
this was clearly not the mechanism that was entirely responsible for CVB3 induced 
cytopathic effect. Below we will outline more mechanisms responsible for cell death and 
that may run parallel to caspase mediated cytotoxicity. Later in this chapter we will also 
cover new systems biology approaches that could be applied toward the understanding of 
the dominant/ pertinent pathways of CVB3 induced cell lysis and the networks employed 
by the virus to drive cell death. 
2.3.2 Glycogen synthase kinase-3β 
In addition to the roles of caspases during cell death, the actions of glycogen synthase 
kinase-3 ǃ (GSK-3ǃ) have also been implicated in the induction of cytopathic effect by CVB3 
replication (Yuan et al., 2005; Zhang et al., 2003). Phosphorylation of transcription factors by 
GSK-3ǃ can lead to either the activation or down-regulation of transcription, and activation 
of GSK-3ǃ has been observed relatively early in the CVB3 replication cycle (Yuan et al. 
2005). The catenins are poly-phosphorylated by activated GSK-3ǃ, leading to degradation in 
the proteasome (Doble and Woodgett, 2003; Harwood, 2001). During CVB3 infection, the 
activation of GSK-3ǃ has been proposed to lead to instability of cell viability due to 
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degradation of a protein called ǃ-catenin (Figure 1C). The catenins interact with the actin 
cytoskeleton and act to maintain morphological integrity by connecting the actin 
cytoskeleton with the cell membrane. The loss of these connections through enhanced GSK-
3ǃ activation and ǃ-catenin degradation is consistent with the profound cell rounding that 
occurs during intermediate to late phases of CVB3 replication. The accumulation of ǃ-
catenin in the cytoplasm leads to translocation into the nucleus where it transactivates 
survival signalling via T-cell factor (TCF)/lymphocyte enhancer factor (LEF) family 
members (Doble and Woodgett, 2003; Hardt and Sadoshima, 2002; Harwood, 2001). 
Consistent with these findings, the inhibition of GSK-3ǃ or the over-expression of ǃ-catenin 
resulted in the suppression of viral progeny release, but not viral protein production (Yuan 
et al., 2005). Therefore GSK-3ǃ is pivotal in regulating the rupture of infected cells for 
progeny release. 
2.3.3 The endoplasmic reticulum unfolded protein response 
CVB3 induces the unfolded protein response (UPR), which is an acute stress response that 
leads to ER stress (Zhang et al., 2010). Poliovirus, CVB3 and other viruses have been shown 
to replicate their genomes and translate protein on the surfaces of double membrane vesicles 
derived from the ER and autophagosomes (Suhy et al., 2000; Wong et al., 2008; Zhang et al., 
2011). This activity in combination with interruption of regular protein translation and a 
massive upregulation of protein production by the virus probably leads to activation of the 
UPR. This process involves 3 different pathways of independent activation, initiated by 3 
respective stress sensors in the proximal ER: ATF6a, IRE1-XBP-1, (X box binding protein 1), 
and PERK (PKR-like ER protein kinase). It has been shown that infection with CVB3 invokes 
activation of ATF6a and XBP-1, possibly through replication of the virus on the surface of 
double membrane vesicles derived from the ER and autophagosome (Wong et al., 2008). 
Other viruses that replicate in the cytosol, such as West Nile Virus, have been shown to 
activate this pathway to promote virus replication and cell death ((Medigeshi et al., 2007) 
review). The UPR response to massive viral protein synthesis and usurped cellular 
pathways most likely acts to initiate or augment the onset of death in the infected host cell. 
However if these pathways are activated too early in the virus replication cycle the cell will 
die before virus protein production and virus progeny can be completed and released, 
respectively. This would surely result in the termination of virus replication. Zhang et al. 
showed that expression of the UPR response protein, XBP-1 acts to delay the onset of cell 
lysis and release of progeny virion (Figure 1B). Therefore, pathways like XBP-1 are used by 
the virus to counter early destruction of the cell; so CVB3 has evolved mechanisms to 
prevent premature death of the infected cell. Major cellular survival pathways, like Akt, are 
also invoked to counter the death reflex, which we will discuss later in the chapter.  
2.3.4 Cell death and lysis through activation of many simultaneous pathways  
The overwhelming and rapid activation of many different pathways simultaneously leads to 
cell death and lysis (Figure 1), liberating progeny virion. It is possible, that cell death 
pathways may even be synergistic, additively driving the cell toward more rapid and thus 
uncontrolled death, leading to lysis. The cytochrome c- caspase-9 pathway requires a 
minimum of 15 hours to kill a cell that has been chemically induced, almost twice as long as 
it takes CVB3 to lyse an infected cell (Qu and Qing, 2004). The plant toxin abrin requires 
upwards of 15 – 36 hours to kill a culture of HeLa cells (Qu and Qing, 2004), the E2 protein 
of human papillomavirus requires 20 – 24 hrs to induce apoptosis (Desaintes et al., 1999), 
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whereas CVB3 will have induced apoptosis and destroyed a similar culture of HeLa cells in 
just 8 – 10 hours. The rapid nature of CVB3 induced cell lysis suggests the synergy between 
numerous death pathways ‘criss-cross’ and interact to enhance their collective cell-death 
effect.  
The loss of checked and contained cell death results in necrosis and lysis of the CVB3 
infected host cell. Even though the pathways of cell death are clearly defined in this arena, 
the precise mechanisms of initiation are still unclear, and potential pathway interactions are 
unknown. Many reports have indicated that a particular pathway may be involved in CVB3 
induced cell death although there hasn’t been 100 % recovery of cell viability demonstrated 
from experiments that inhibit just one pathway. However, zVAD, a pan caspase inhibitor 
does not completely inhibit virus induced death and lysis just as GSK3ǃ inhibition doesn’t 
completely inhibit cell-rounding and death. Therefore there is still much to be learned about 
the initiation and interaction of cell death pathways during CVB3 infection, but we may 
never be able to completely inhibit CVB3 induced cell death because once virus replication 
is initiated the cell may already be past the threshold of viability. 
2.3.5 Necroptosis?  
Necroptosis (necrotic apoptosis) is a tumour necrosis factor receptor activated form of 
programmed cell death that is activated by the same class of receptors that activate caspase-
8 mediated apoptosis (Declercq et al., 2009; Hitomi et al., 2008; Yuan and Kroemer, 2010). 
This is a more recently discovered pathway of cell death that has not been reported in the 
context of CVB3 infection. However, instead of caspase-8 activation that normally results 
from TNF receptor ligation there is activation of a receptor interacting protein (RIP)-1/RIP-3 
pathway that results in rupture of the cell through loss of membrane integrity; a mode of 
cell death reminiscent of CVB3 induced cell lysis. Transgenic caspase-8 null animals 
undergo RIP-3 necroptosis instead of apoptosis, leading to embryonic lethality and non-
viability of the line. However caspase-8 -/-, RIP-3 -/- double transgenic mice are viable, 
suggesting that caspase- 8 holds RIP-3 ‘in check’, preventing initiation of programmed 
necrosis (Kaiser et al., 2011). The necroptosis pathway has not yet been described with 
respect to CVB3 infection but given the similarities between CVB3 induced cell lysis and 
necroptosis this pathway of cell death and the RIP-1/RIP-3 proteins may provide some 
insight.  
2.4 Virus induced cell death and lysis – ‘Timing is everything’  
There have been reports showing that cell death activated early in the virus life cycle 
significantly inhibits viral replication (Zhang et al., 2010). Release of the cell contents prior to 
progeny virion production and more programmed processes of cell death will halt virus 
replication by killing the cell prior to assembly of progeny virus virion or confinement of 
progeny virion into vimentin cages, respectively.  
Virus replication is cytotoxic and can cause cell death before production of progeny virion, 
terminating the life-cycle of the virus. For example, reactive oxygen species are a byproduct 
of CVB3 replication very early in the life-cycle of the virus, placing stress on the cell such 
that the mitochondrial cytochrome c pathway of caspase-9 mediated cell death might be 
activated prior to virion assembly. To prevent premature death of the host cell 
coxsackievirus triggers the activation of pro-survival proteins and their associated cascades 
to suppress cell lysis until progeny virion can be assembled. Perhaps the most studied pro-
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survival protein, Akt, is activated during the CVB3 replication cycle (Esfandiarei et al., 2007; 
Esfandiarei et al., 2004; Liu et al., 2008). It may appear counter-intuitive for a cytolytic virus 
to evolve to activate pro-survival pathways, particularly if the virus requires the cell to lyse 
at the end of the cycle. However, as we discussed in section 2.1 CVB3 replication is cytotoxic 
from the onset so pro-survival pathways may be selected evolutionarily to support the 
survival of the cell while viral protein synthesis and viral progeny assembly are taking 
place. These mechanisms of cell survival during virus infection act in favour of viral 
replication because they allow maximum amounts of virus progeny to be assembled prior to 
cell lysis and release of viral progeny. Subsequently, these same survival pathways must be 
inhibited to then permit cell death and lysis for release of assembled viral progeny virions.  
2.5 Coxsackievirus induced cell death: many dimensions of complexity 
It is now apparent that several cell death pathways and perhaps dozens of proteins are 
activated in a web of molecular interaction in order to short circuit normal death 
mechanisms, to cause rapid and aberrant rupture of the infected cell (Figure 1). New 
pathways of cell death, such as necroptosis, may as yet be shown to mediate death of the 
CVB3 infected cell. Nevertheless, there already exists a large web of seemingly disparate 
pathways of CVB3 induced cellular lysis. As we discussed earlier, it is difficult to determine 
the foundation pathway that is responsible for virally induced cell lysis of infected 
cardiomyocytes, and which ones are triggered, merely as a matter of coincident activation. 
New methods of data organisation and analysis are clearly needed as more pathways and 
mechanisms of CVB3 induced cell death are revealed. Knowledge of the truly pertinent and 
central pathways of cell death could lead to the most robust antivirals. Toward the end of 
this chapter we will discuss the use of systems biology to organise the myriad of pathways 
activated during CVB3 infection (proteolytic and kinase) and how it could be applied to 
elucidate the dominant pathways of virus induced cell death. 
3. Inflammatory regulation of myocarditis by the host: regulatory T cells and 
healthy vs pathological signalling 
3.1 Mouse genetic determinants of immune infiltration 
Once virus infection has taken hold in the heart there is infiltration and onset of immune 
responses to clear infection and lay down provisional matrix in place of damaged tissue. As 
we discussed earlier in the chapter, the severity of the immune response varies broadly from 
patient to patient, from mild to massive immune infiltration that can lead to DCM and 
congestive heart failure. We know from the mouse models of CVB3 induced myocarditis 
that immune infiltration is correlated with the amount of virus inoculum, and therefore with 
the degree of damage that has been mediated by virus. However experiments comparing 
the susceptibility of various inbred strains of mice to CVB3 induced myocarditis showed 
that there could be a genetic predisposition to myocarditis severity (McManus et al., 1993). 
These data suggest that a genetic predisposition of the individual patient to mild or severe 
myocarditis, combined with viremia and cardiac viral load could act in concert to determine 
severity and number of myocarditic foci. The studies conducted with inbred mouse strains 
have implicated the MHC class II (H2) locus (Wolfgram et al., 1986), in addition to other 
genetic loci (Traystman et al., 1991) associated with the severity and susceptibility to CVB3 
myocarditis, both acute, chronic and autoimmune. Not surprisingly, the H2 locus of the 
MHC II complex has been implicated in clearance of acute coxsackievirus infection 
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Fig. 1. Pathways of cell death in CVB3 infected cardiomyocytes. A. Coxsackievirus 
replication results in production of reactive oxygen species which promote the release of 
cytochrome c from mitochondria. The formation of Bak and Bax at the membrane surface 
mediate passage of cytochrome c into the cytosol. Overexpression of the anti-apoptotic 
proteins BCl 2 and BCl-XL during CVB3 infection significantly reduce cytochrome c release 
and activation of the caspase-9 pathway of apoptosis, which leads to caspase-3 death 
effector caspase activation. ROS = reactive oxygen species. B. The unfolded protein response 
(UPR) of the endoplasmic reticulum (ER) is activated during CVB3 infection of 
cardiomyocytes leading to activation of all 3 known pathways of the UPR: spliced XBP-1s, 
PERK and ATF6a ER stress sensors are all activated during CVB3 infection. Virus replication 
occurs on the surface of double membrane vesicles and membrane derived from the ER, 
activating the ER stress sensors. The result of XBP-1s activation is to slow the onset of cell 
death to prevent the cell from rupturing prior to the assembly of progeny virus virions. UPR 
= unfolded protein response. C and D. Glycogen synthase kinase -3ǃ (GSK-3ǃ) is activated 
during CVB3 infection resulting in phosphorylation and subsequent proteosomal 
degradation of its target, ǃ –catenin, in the cytosol. C. Loss of ǃ –catenin in the cytosol 
results in loss of connections between the actin cytoskeleton and cadherin receptors, via 
connections to ǂ and ǃ –catenins. D. Less ǃ –catenin in the cytosol means that there will be 
less available to translocate across the nucleus to activate survival gene expression via TCF 
and TBP transcription factors.  
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(Wolfgram et al., 1986). The presence of a strong adaptive response that includes robust 
neutralising antibodies is required to control CVB3 infection in mice (Wolfgram et al., 1986) 
and patients (McKinney et al., 1987; Misbah et al., 1992), as well as other picornaviruses, like 
polio (MacLennan et al., 2004). Therefore, the host’s own genetic makeup will determine 
how quickly and how completely virus infection is cleared from the body. An inability to 
mount a broad immune response will lead to more virus replication, more immune 
infiltraton of the myocardium, more matrix deposition and longer recovery times. In 
addition to these host dependent factors there may also be environmental factors that play 
roles during infection and inflammation: extrinsic source stress, pollution/allergens and 
population density could also contribute to susceptibility and severity of viral myocarditis.  
3.2 Chronic infection and the cycle of virus-immune mediated damage 
Over the last 3 decades it has become apparent that viral load is a primary determinant of 
viral myocarditis severity (Cheung et al., 2008; Chow et al., 1992; Lim et al., 2005; Marchant 
et al., 2009a; McManus et al., 1993), the virus causes extensive, early direct injury to the 
myocardium through its replication. The studies cited above all indicate significant injury to 
the myocardium prior to cardiac immune infiltration, supporting the view that considerable 
damage to the heart is directly mediated by the virus alone. An argument has been made 
previously for the importance of chronic virus replication in myocarditis and as a basis of 
dilated cardiomyopathy (Szalay et al., 2006) and chronic heart failure. Enhanced 
immunoproteasome expression in chronically CVB3 infected cardiomyocytes (Szalay et al., 
2006) may increase the expression and presentation of auto-antigens, leading to more severe 
myocarditis through autoimmune avenues. Chronic virus replication will lead to consistent 
damage which will, in turn, result in provisional matrix turnover. This type of damage-
repair loop will propagate the fibrosis that is evident during chronic myocarditis and DCM. 
As we covered in the apoptosis/death pathway sections of this chapter the release of cell 
constituents and debris, and progeny virus and proinflammatory cytokines, from an 
infected cell will lead to inflammation at the site of virus insult. Therefore, the damage 
inflicted by the virus itself will be exacerbated by the onset of cytolytic immune infiltration 
and fibrosis.  
3.3 Regulatory T cells 
Not all T cell infiltration and immunity are harmful as there are moderating arms of the 
immune response that solely act to moderate the strength of a response, preventing 
autoimmunity. Li et al recently reported that allografted M2 (anti-inflammatory) 
macrophages led to improvement of virus-induced myocarditis (Li et al., 2009) which was 
associated with enhanced levels of regulatory T cells (Treg). Huber et al have also reported 
decreased viral load and immune infiltration after adoptive transfer of a CD4+ CD25+ 
regulatory-like T cell population into a mouse model of CVB3 infection (Huber et al., 2006). 
Regulatory T cells are CD4 + cells that express the -subunit of the IL2 receptor CD25, and 
are negative for CD127. The hallmark protein expressed in these cells is the transcription 
factor FoxP3 and they circulate as a functionally distinct T cell subpopulation, preventing 
autoimmune and other aberrant responses to innocuous environmental antigens (Wing and 
Sakaguchi). The T-reg population prevents the proliferation of self-reactive effector T cell 
populations and were aptly named suppressor T cells when first discovered for their ability 
to secrete IL10 and moderate Th1 immunity (Wing and Sakaguchi). Thus, it would be 
reasonable to postulate that adoptive transfer of T-regs into a mouse model of viral 
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myocarditis would suppress the immune response and allow virus replication to proceed 
unchecked. 
In a study by Shi et al (Shi et al., 2010) T-reg cells were adoptively transferred into CVB3 
infected mice and the effect of the transferred cells upon viral load and signalling within the 
heart were investigated. Included in the study were PBS injection controls, but also naïve T 
cells. Decreased immune infiltration and enhanced Akt activation, as compared to the naïve 
CD4 T cell and PBS grafted controls, were notable in the T-reg adopted mice (Figure 2). 
Perhaps the most surprising of the results was the decreased viral load, not only in the heart 
but also in the pancreas and spleen, associated with lower expression of the Coxsackie- 
Adenovirus Receptor (CAR). The authors adoptively transferred, not only T-reg cells, but 
CD25 (-) CD4 T cells (naïve) as well (Figure 2A), into a separate group of mice. In fact, the 
naïve CD4 T cell treated control group fared worse than either the PBS or T-reg treated 
groups, related to less Akt activation and higher CAR receptor expression. As a result, the 
naive T cell population brought on a more severe myocarditis phenotype due to higher viral 
loads. Taken altogether, Shi et al. describe the protective role that T-reg cells play in immune 
infiltration of the heart during viral myocarditis, suggesting that there is a balance to be 
struck between clearance of infection and immune-associated damage to the myocardium. 
In fact, in this study there was observed decreased viral loads consonant with a decrease in 
immune infiltration due to reduced TNF-ǂ release and lower CAR expression (Figure 2B). 
The authors found that though TNF-ǂ could enhance CAR expression in mouse 
cardiomyocytes the co-addition of TGF-ǃ eliminated TNF-ǂ-induced CAR expression. To 
conclude, these findings suggest a more intimate link between inflammation and virus 
replication than previously posited. Thus, moderating the immune response may be critical 
for prevention of chronic virus replication.  
Although the dominant factor in virus suppression during T-reg treatment was most likely 
down-regulation of CAR expression, we propose that the alteration in signaling evoked by 
T-regs is also playing a significant role in modulating virus replication. The basis of our 
argument is that CAR expression was suppressed 3-fold in vivo and 5-fold in a dividing 
cardiomyocyte cell line in vitro, but the suppression of viral load in the Treg group was 
almost 2-logarithms reduced as compared to the control group. Although the correlation 
between cell receptor expression and virus infection may not be linear, the decreased levels 
of CAR receptor may not explain the entire antiviral effect of T-regs in the myocardium 
during virus infection. It is entirely possible that the signalling environment altered by the 
adoptive transfer of T-regs may have also contributed to a less favorable environment for 
virus replication. The authors reported activation of Akt in the myocardium of the T-reg 
treated groups, which suggests that the activation of other signalling proteins may have 
been altered by T-reg transfer. We have reported that Akt activation is required for 
successful CVB3 replication (Esfandiarei et al., 2007; Esfandiarei et al., 2004; Esfandiarei et 
al., 2006), a pro-survival protein required by the virus to optimize the longevity of the 
infected cell to promote optimal progeny virus production. On the other hand, the Akt 
activation reported by Shi et al. may merely be a reflection of a healthier environment 
created by allografted T-reg cells in the myocardium. It is quite clear that an unbraked 
immunologically active environment supports enhanced cellular signalling driven by 
viruses for successful replication (Esfandiarei et al., 2006; Marchant et al., 2009a; Marchant et 
al., 2008). For example, we have previously reported that the powerful immune-stimulating 
protein p38 is required for effective virus replication in a CVB3 myocarditis mouse model 
(Marchant et al., 2009a). The activation of p38 MAP kinase was not investigated by Shi et al., 
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but we would predict less net activation of p38 in the presence of T-regs, and thus an 
environment that is less conducive to virus replication. Although p38 MAP kinase activation 
is required for suppressor (T-reg) T cell activity and function (Adler et al., 2007), we propose 
that adoptive transfer of T-regs may have decreased the immune infiltrate in the 
myocardium with less activation of p38 MAP kinase.  
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Fig. 2. Adoptive transfer of T cells into CVB3 infected mice has assisted in the elucidation of 
the beneficial arms of the immune response that aid in clearance of virus from the heart. A. 
Transfer of naïve T cells or control treatment with PBS, followed by infection with CVB3 
results in high viral load in the heart followed by a large influx of T cells. An indication of 
myocarditis in the mouse model  is the detection of decreased Akt activation, and MMP, 
TNF-ǂ, and IFN-Ǆ expression. Shi et al demonstrated that TNF- ǂ induces coxsackie-
adenovirus receptor (CAR) expression in myocardium  during CVB3 replication which may 
promote chronic virus replication which could lead to dilated cardiomyopathy and  heart 
failure through successive rounds of provisional matrix deposition and degradation. B. 
Adoptive transfer of syngeneic regulatory T cells reduces the immunologically reactive 
environment which results in less MMP, TNF-ǂ, and IFN-Ǆ expression. The result is lower 
CAR expression, lower viral loads and enhanced Akt activation, leading to a healthier, less 
immunologically reactive environment.  
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3.4 ERK and p38 MAP kinases 
Activation of p38 MAP kinase is required for virus replication to take place, such that 
inhibition of p38 MAP kinase is an effective antiviral strategy in vitro (Si et al., 2005) and in 
vivo (Marchant et al., 2009a). The activation of ERK MAP kinase was first reported in the 
context of CVB3 infection both in vitro (Luo et al., 2002) and in vivo (Opavsky et al., 2002). 
The activation of this molecule by virus binding the CAR receptor may be involved in 
triggering endocytosis uptake of CVB3 during entry (Marchant et al., 2009b). The activation 
of p38 MAP kinase was later shown to be required for cell lysis and release of progeny 
virion. Si et al reported that inhibition of p38 MAP kinase could block progeny virus 
production but not virus protein expression (Si et al., 2005). Underlining the importance of 
p38 during virus replication was a relatively recent study that investigated the role of p38 
during the life cycle of several different viruses. The activation of p38 MAP kinase was 
demonstrated as a common and dominant signalling molecule during the replication of 
many different types of viruses (Marchant et al., 2010). This molecule’s intimate link to the 
immune response is perhaps not surprising; one might expect that Akt activation, p38 
inhibition and T-reg immune control lead to improved outcome and result in lower viral 
load and immune infiltration.  
With regard to new treatment strategies, this does not necessarily mean that we should be 
injecting T-reg cells into afflicted patients, but methods should be pursued that mediate the 
immune response to swing the pendulum in favor of viral clearance and reparation, and 
away from immune infiltration of the myocardium that favors higher viral loads. The work 
of several recent studies [(Li et al., 2009; Shi et al., 2010) reviewed in (Yajima and Knowlton, 
2009)] have demonstrated the virus’ evolved ability to bias immune activation and 
associated signaling queues for the benefit of virus replication. Given the results presented 
by Shi et al., one might initially conclude that immune suppression would be a sound 
therapeutic strategy. However the Myocarditis Treatment Trial, wherein patients were 
treated with immunosuppressive agents (Mason et al., 1995), showed that such 
administration had no significant benefit for outcome of human myocarditis. As such, pan-
immune suppression is not the way forward and better targeted methods of immune 
modulation are needed. Shi et al. demonstrated that TGF-ǃ secreted by T-reg cells may have 
been responsible for the decreased CAR expression and enhanced Akt activation (Figure 1). 
Such suggests that we need not inhibit the immune response entirely, but rather target, 
modulate and encourage the arm of the immune system that promotes virus clearance. The 
way forward may not be adoptive transfer of T-regs, but administration of a drug that can 
promote T-reg differentiation and function.  
3.5 The matrix metalloproteinases 
The Matrix MetalloProteinases (MMPs) have been implicated in the immune response to 
CVB3 infection in addition to delaying matrix remodelling that takes place after acute 
infection. 
The MMPs are collectively termed ‘matrixins’ and were first discovered for their ability to 
degrade the tails of tadpoles during frog morphogenesis (Visse and Nagase, 2003). These 
enzymes are zinc endoproteinases and there have since been 24 vertebrate MMP genes 
discovered that play a large number of roles during immune and developmental processes. 
There are several gene knock-out strains of MMPs that have been used to elucidate the roles 
of these enzymes during development and immunity. For example, MMP-8-/- mice are more 
prone to skin cancers due to delayed neutrophil infiltration and an aberrant immune 
response (Balbin et al., 2003). Matrix MetalloProteinase-12-/- mice are more susceptible to 
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bacterial infection due to an innate antimicrobial property of MMP-12 in intracellular 
compartments (Houghton et al., 2009). This MMP was shown to bind to bacterial 
membranes within the endosomes of macrophages and destabilise bacteria, thus acting as 
an antimicrobial.  
3.5.1 MMPs as modulators of the antiviral immune response 
MMP-9 was one of the first MMPs to be implicated in the mechanism of myocarditis and 
cardiac dilatation. Heymans et al first showed that inhibition of MMP action through 
suppression of urokinase-type plasminogen activator, a potent activator of MMPs, and 
exogenous expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) decreased cardiac 
inflammation and reduced myocardial necrosis at 7 days, decreasing cardiac fibrosis at 35 
days after CVB3 infection (Heymans et al., 2006). When the activity of MMP-2 and -9 were 
decreased there was a concomitant recovery of cardiac function with decreased immune 
infiltration. However, shortly after the publication of this paper Cheung et al demonstrated 
that MMP-9 was in fact a necessary constituent of the antiviral immune response (Cheung et 
al., 2008). They demonstrated no difference in viral load between MMP-8-/- mice and their 
WT counterparts. However, MMP-9-/- mice had higher viral loads and virus mediated 
myocardial damage, during CVB3 infection. Though the antiviral mechanism of MMP-9 
action was not explicitly reported, there were significantly elevated levels of interferon-ǃ 
(IFN-ǃ) in the MMP-9-/- mice. This MMP has been shown previously to cleave and inactivate 
IFN-ǃ (Nelissen et al., 2003), and IFN-ǃ is known to have a negative feedback effect upon 
IFN-Ǆ expression (Hanada and Yoshimura, 2002; Yoshimura et al., 2003). The viral loads 
were similar at early time points (3 – 5 days) post-infection between the genetic MMP-9 
knock-outs and WT mice, suggesting that the innate-early immune response was intact, but 
there were higher viral loads seen in the MMP-9-/- mice 9 days post-infection. These results 
suggest that there was a deficiency in adaptive immunity in the MMP-9-/- mice, consistent 
with IFN-ǃ negative feedback inhibition on IFN-Ǆ regulated adaptive immunity in the 
MMP-9-/- mice.  
4. Virus induced cell signalling and global aspects of cellular signalling 
responses 
Thus far we have discussed a large number of parallel signalling molecules and pathways 
that are simultaneously activated during CVB3 infection, from proteolytic death pathways 
to phospho-signalling kinase cascades that activate a myriad of functions. Systems biology 
approaches now exist whereby one may survey a large number of pathways and molecules 
at the same time, query these results using complex statistical methods and elucidate the 
pathways that are truly required for a particular pathogenic function, and determine which 
of those that are merely coincident to viral infection. 
4.1 Defining cell signalling network models in virus-host interactions 
Host cells have evolved complex systems to detect and eradicate viruses; on the other hand, 
viruses have evolved mechanisms to compromise essential cellular processes and suppress 
the host cell defence. In these complex systems, protein phosphorylation events control most 
aspects of cellular function and homeostasis, and the failure of control mechanisms causes 
disease (Cohen and Tcherpakov, 2010). Most notably, protein phosphorylation events 
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mediated by kinases and phosphatases are used by viruses as they are crucial for pathogen 
replication, propagation, and evasion from host immune responses (Ribet and Cossart, 
2010). Several studies have showed that multiple phosphorylated-proteins individually 
regulate the events that constitute virus replication [reviewed in (Esfandiarei and McManus, 
2008)], yet the phospho-proteins are part of an intracellular signal-transduction network, 
composed of several pathways. Thus, systems perspective studies have enabled us to 
address network mechanisms active during host-virus interactions, with specific emphasis 
on elucidating key determinants of disease severity and the effective translation of these 
concepts into new systems-oriented therapeutic targets. 
Virus infection is equivalent to a network perturbation, in that viruses have evolved 
effective strategies to manipulate multiple signalling pathways and induce crosstalk and 
feedback loops among pathways to form a network (Garmaroudi et al., 2010). In fact, 
viruses activate signal-transduction networks through multiple independent events, which 
include viral docking to receptors, viral protein synthesis, viral progeny release and virus-
induced inflammatory responses (Tam, 2006). Thus, to properly understand how signal-
transduction networks are disrupted by viruses, a global multivariate approach is required 
(Ideker et al., 2001; Kleppe et al., 2006).  
One of the major challenges of defining a signal-transduction network model in the 
context of a disease is to study a holistic picture of molecular structures, coming together 
to make complex and dynamic networks. New tools are required to systematically perturb 
and monitor signalling processes and functions within cells. Indeed, the emergence of 
high-throughput, extremely parallel technologies enable biologists to monitor multiple 
cellular components all together (Albeck et al., 2008). These tools have provided 
researchers the opportunity to collect comprehensive and large datasets. Nowadays, in 
the era of “new biology” researchers are ‘drowning’ in data, in that one emerging 
challenge is how to organize, interpret and extract pertinent information. The complex 
web of death pathways discussed in section 2.3 or the complex nature of the immune 
response discussed in section 3.0, all argue a need for higher level analysis through 
machine learning. Though this analysis requires skilled computational biologists, using 
mathematical, statistical and computational techniques to put together the biological 
components into functional molecular and cellular network models in a systematic 
fashion (Janes and Yaffe, 2006).  
One work that has emerged from recent studies of networked systems in the virus-
infected host cell revealed ~260 host cellular factors, affecting virus infection (Brass et al., 
2008), however only a small subset of these proteins played a role in the early stage of 
virus infection. Interestingly, a complementary study showed how a multi-parameter 
approach could unravel host-virus protein interactions that likely act as a network to 
facilitate the early steps of HIV-1 infection (Konig et al., 2008). Recently, small-molecule 
inhibitor pairs were used to perturb pairs of phospho-proteins to reveal causal 
mechanisms within the signal-transduction network response of cardiomyocytes to 
coxsackievirus B3 (CVB3) infection. Hierarchical cluster analysis of the resulting dataset 
showed that paired-inhibitor data was required for accurate predictions of the network. In 
this study we also depicted a high-confidence network based on partial correlations, 
which identified phospho-IкBǂ as a central “hub” in a measured phosphorylation 
signature (Garmaroudi et al., 2010). Now, biologists are poised to understand the network 
mechanisms in virus infection, in that these networks might be used to improve patient 
diagnosis, monitoring, and treatment. 
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4.2 Proposing novel therapeutic targets for viral myocarditis through systems biology 
analysis of host cell signal-transduction networks 
As we have already discussed, cardio-tropic viruses like CVB3 can directly and indirectly 
further the progression of viral myocarditis to heart failure [(McManus et al., 1993) reviewed 
in (Marchant et al., 2008)]. To date, there is no curative treatment beyond heart 
transplantation for viral myocarditis-associated heart failure. Therapies that have been used 
in patients with myocarditis are immune serum globulin and pleconaril (Pevear et al., 1986; 
Rotbart, 1999). The anti-picornaviral agent, pleconaril perturbs viral uncoating and in turn 
blocks viral attachment to host cell receptors. Although, directly targeting viruses has been 
successful in controlling viral diseases, it suffers from some serious weaknesses, including 
failure to eliminate chronic viral myocarditis, narrow spectrum of action, and the inherent 
capacity to force outgrowth of drug resistance mutations (Tan et al., 2007). Thus, the 
discovery of novel antiviral targets, host cell-based antiviral agents is a more promising 
approach and deserves more attention (Saladino et al., 2010).  
At the cellular level, studies have shown that host cell phospho-proteins essential for viral 
replication, are potentially targetable [(Marchant 2009) reviewed in (Marchant et al., 2008)]. 
It is known, however, that phospho-protein networks embrace a system that contains 
redundant, convergent and even distinct signaling pathways (Borisy et al., 2003). Such 
combinative properties of signaling networks may counteract the therapeutic efficacy of 
highly selective drugs due to signalling pathway redundancy. Thus, combination therapy 
may be necessary to achieve efficacy due to less treatment resistance (Fitzgerald et al., 2006). 
However, motivation for this initiative, therapeutic synergy of a combination is tempered by 
concerns about introducing synergistic side effects. Nevertheless, an in vivo study that has 
emerged from recent studies of the healing process in a rat asthma model showed that 
combining drugs performed better than single ones (Lehar et al., 2009). 
Together, to propose novel and promising drugs and therapies requires us to understand 
network mechanisms at the cellular, tissue and organism level. Using high-throughput 
technologies in genomics, proteomics, phosphoproteomics, metabolomics and lipidomics, 
we can develop interactome network models, in that these models ultimately translate to 
network analysis and data-driven questions in a specific disease context, that can be used to 
analyse a broad range of different states and disease contexts. There have been recent 
reports that used systems biology analysis tools in an attempt to untangle the web of kinase 
signalling pathways that are activated during CVB3 infection of cardiomyocytes 
(Garmaroudi et al., 2010). There is a current unclaimed niche of research that exists to use 
similar systems biology tools to analyse the pathways of cell death in order to better 
understand not only the dominant pathways of virus induced cell death but to also 
characterise the type of cell death that causes necrotic rupture of infected cells. To perturb 
specific molecules or biological processes in a combination as directed by network models 
can be a capable strategy to treat complex diseases. 
5. Conclusion  
In every facet of CVB3 replication there are a large number of pathways and proteins 
involved, forming a large network of pathways and complexity too large to analyse by 
conventional means. The large number of death pathways activated by CVB3 may not all be 
required to mediate lysis of the infected host cell. The question still remains as to whether 
there are pathways activated as a matter of coincidence or whether death pathways are all 
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consequential. There are also a large number of immune constituents involved in the 
clearance but also the pathogenesis of myocarditis, from naive T cells to regulatory T cell 
subsets and a large number of MMPs. Systems biology should prove useful in the near 
future to elucidate the interactions of proteins and pathways and show the truly pertinent 
proteins and pathways responsible for cell death, virus replication or MMP mediated tissue 
remodelling. New questions regarding pathway coincidence and consequence can be 
investigated. New methods of analysis should assist in the understanding of beneficial vs 
pathological arms of the immune system. With this knowledge we should be able to design 
highly useful and robust biomarkers, antivirals and drugs to help direct appropriate repair 
and remodelling. 
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